Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 321 citing Li: Meta-analysis: pharmacologic treatment of obesity. (0.10 sec) 

Long term pharmacotherapy for obesity and overweight: updated meta-analysis

- nih.gov
D Rucker, R Padwal, SK Li, C Curioni, DCW … - British Medical Journal, 2007 - bmj.com
Page 1. doi:10.1136/bmj.39385.413113.25 published online 15 Nov 2007; BMJ Diana
Rucker, Raj Padwal, Stephanie K Li, Cintia Curioni and David CW Lau ...
Cited by 160 - Related articles - BL Direct - All 6 versions

Obesity in older adults: technical review and position statement of the American Society for …


DT Villareal, CM Apovian, RF Kushner, S … - American Journal of Clinical Nutrition, 2005 - ajcn.cnfindpark.cn
Obesity causes serious medical complications and impairs quality of life.
Moreover, in older persons, obesity can exacerbate the age-related decline in
physical function and lead to frailty. However, appropriate treatment for ...
Cited by 143 - Related articles - BL Direct - All 12 versions

Pharmacologic and surgical management of obesity in primary care: a clinical practice …

- annals.org
V Snow, P Barry, N Fitterman, A Qaseem, K … - Annals of internal medicine, 2005 - Am Coll Physicians
This guideline is based on the evidence report and accompanying background
papers developed by the Southern California Evidence-Based Practice Center. The
American College of Physicians nominated this topic to the Agency for ...
Cited by 118 - Related articles - All 7 versions

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

- nih.gov [PDF] 
M Heilig, M Egli - Pharmacology and Therapeutics, 2006 - Elsevier
Alcoholism is a major public health problem and resembles, in many ways, other
chronic relapsing medical conditions. At least 2 separate dimensions of its
symptomatology offer targetable pathophysiological mechanisms. Systems that ...
Cited by 95 - Related articles - All 5 versions

Birth outcomes in obese women after laparoscopic adjustable gastric banding

- nursing2008.com
JB Dixon, ME Dixon, PE O'Brien - Obstetrics & Gynecology, 2005 - journals.lww.com
Skip Navigation Links Home > November 2005 - Volume 106 - Issue 5, Part 1 >
Birth Outcomes in Obese Women After Laparoscopic Adjustable... ... From the
Australian Centre for Obesity Research and Education, Monash Medical ...
Cited by 71 - Related articles - All 6 versions

Pharmacotherapy for obesity

- adisonline.com [PDF] 
LL Ioannides-Demos, J Proietto, JJ McNeil - Drugs, 2005 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . 1391 1. Drug Therapy: Mechanism of Action and Efficacy . . . ...
Cited by 70 - Related articles - BL Direct - All 6 versions

Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a …


R Christensen, EM Bartels, A Astrup, H … - British Medical Journal, 2007 - ard.bmj.com
This review aims to assess by meta-analysis of randomised controlled trials
(RCTs) changes in pain and function when overweight patients with knee
osteoarthritis (OA) achieve a weight loss. Systematic searches were ...
Cited by 52 - Related articles - BL Direct - All 4 versions

Drug treatment of the overweight patient


GA Bray, DH Ryan - Gastroenterology, 2007 - Elsevier
Three medications with approval for long-term use in the treatment of obesity
are currently available in the United States. Sibutramine (US Food and Drug
Administration [FDA] approved in 1997), orlistat (FDA approved in 1999), ...
Cited by 47 - Related articles - All 20 versions

Safety of drug therapies used for weight loss and treatment of obesity


LL Ioannides-Demos, J Proietto, AM Tonkin, … - Drug safety, 2006 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 277 1. Drug Therapy . . . . . . . . . . . . . . . . . . . . ...
Cited by 41 - Related articles - BL Direct - All 8 versions

[PDF] Obesity drugs in clinical development


JCG Halford - Current Opinion in Investigational Drugs, 2006 - biomedcentral.com
A number of anti-obesity drugs are currently undergoing clinical development.
These include: (i) centrally-acting drugs, such as the noradrenergic and
dopaminergic reuptake inhibitor radafaxine, the endocannabinoid antagonist ...
Cited by 40 - Related articles - View as HTML - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google